Literature DB >> 24909933

Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.

Brandon M Teska1, Javier Alarcón, Ronald J Pettis, Theodore W Randolph, John F Carpenter.   

Abstract

The stability of three commercial "fast-acting" insulin analogs, insulin lispro, insulin aspart, and insulin glulisine, was studied at various concentrations of phenolic preservatives (phenol and/or meta-cresol) during 9 days of incubation at 37 °C. The analysis by both size-exclusion and reversed-phase chromatography showed degradation of lispro and aspart that was inversely dependent on the concentration of phenolic preservatives. Insulin glulisine was much more stable than the other analogs and showed minimal degradation even in the absence of phenolic preservatives. With sedimentation velocity ultracentrifugation, we determined the preservatives' effect on the insulins' self-assembly. When depleted of preservatives, insulin glulisine dissociates from higher molecular weight species into a number of intermediate molecular weight species, in between monomer and hexamer, whereas insulin aspart and insulin lispro dissociate into monomers and dimers. Decreased stability of insulin lispro and insulin aspart seems to be because of the extent of dissociation when depleted of preservative. Insulin glulisine's dissociation to intermediate molecular weight species appears to help minimize its degradation during incubation at 37 °C.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  drug-excipient interaction; excipients; peptides; protein aggregation; protein formulation; proteins; self-assembly; stability; stabilization

Mesh:

Substances:

Year:  2014        PMID: 24909933     DOI: 10.1002/jps.24039

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Analyzing insulin samples by size-exclusion chromatography: a column degradation study.

Authors:  Brandon M Teska; Amit Kumar; John F Carpenter; Michael F Wempe
Journal:  J Pharm Sci       Date:  2015-01-07       Impact factor: 3.534

2.  Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

Authors:  Christian Fogt Hjorth; František Hubálek; Jonatan Andersson; Christian Poulsen; Daniel Otzen; Helle Naver
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

Review 3.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

4.  Insulin Storage: A Critical Reappraisal.

Authors:  Lutz Heinemann; Katarina Braune; Alan Carter; Amin Zayani; Laura A Krämer
Journal:  J Diabetes Sci Technol       Date:  2020-01-29

5.  An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation.

Authors:  W Kenneth Ward; Gabriel Heinrich; Matthew Breen; Sheila Benware; Nicole Vollum; Kristin Morris; Chad Knutsen; Joseph D Kowalski; Scott Campbell; Jerry Biehler; Mark S Vreeke; Scott M Vanderwerf; Jessica R Castle; Robert S Cargill
Journal:  Diabetes Technol Ther       Date:  2017-02-21       Impact factor: 6.118

6.  Comparison of NMR and Dynamic Light Scattering for Measuring Diffusion Coefficients of Formulated Insulin: Implications for Particle Size Distribution Measurements in Drug Products.

Authors:  Sharadrao M Patil; David A Keire; Kang Chen
Journal:  AAPS J       Date:  2017-08-08       Impact factor: 4.009

Review 7.  Engineering biopharmaceutical formulations to improve diabetes management.

Authors:  Caitlin L Maikawa; Andrea I d'Aquino; Rayhan A Lal; Bruce A Buckingham; Eric A Appel
Journal:  Sci Transl Med       Date:  2021-01-27       Impact factor: 17.956

8.  Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping.

Authors:  Meghomukta Mukherjee; Debajyoti Das; Jit Sarkar; Nilanjan Banerjee; Jagannath Jana; Jyotsna Bhat; Jithender Reddy G; Jagadeesh Bharatam; Samit Chattopadhyay; Subhrangsu Chatterjee; Partha Chakrabarti
Journal:  iScience       Date:  2021-05-21

9.  Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Authors:  Adam Mulka; Brianne E Lewis; Li Mao; Roshanak Sharafieh; Shereen Kesserwan; Rong Wu; Donald L Kreutzer; Ulrike Klueh
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-26

10.  Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.

Authors:  Klaus Gast; Anja Schüler; Martin Wolff; Anja Thalhammer; Harald Berchtold; Norbert Nagel; Gudrun Lenherr; Gerrit Hauck; Robert Seckler
Journal:  Pharm Res       Date:  2017-07-31       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.